4.6 Article

The Smn-Independent Beneficial Effects of Trichostatin A on an Intermediate Mouse Model of Spinal Muscular Atrophy

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy

Justin G. Boyer et al.

HUMAN MOLECULAR GENETICS (2014)

Article Multidisciplinary Sciences

Dissection of the Transversus Abdominis Muscle for Whole-mount Neuromuscular Junction Analysis

Lyndsay Murray et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)

Article Clinical Neurology

Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid

Sanne Piepers et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)

Article Biochemistry & Molecular Biology

Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model

Melissa Bowerman et al.

HUMAN MOLECULAR GENETICS (2010)

Article Neurosciences

Neurodevelopmental Consequences of Smn Depletion in a Mouse Model of Spinal Muscular Atrophy

Hong Liu et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2010)

Article Neurosciences

Valproic acid blocks excitability in SMA type I mouse motor neurons

Kristen Rak et al.

NEUROBIOLOGY OF DISEASE (2009)

Article Clinical Neurology

Sustained Improvement of Spinal Muscular Atrophy Mice Treated with Trichostatin A Plus Nutrition

Heather L. Narver et al.

ANNALS OF NEUROLOGY (2008)

Article Clinical Neurology

Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons

Xuefei Wu et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)

Article Medicine, Research & Experimental

Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy

Amy M. Avila et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Biochemistry & Molecular Biology

The role of histone acetylation in SMN gene expression

LE Kernochan et al.

HUMAN MOLECULAR GENETICS (2005)

Article Biochemistry & Molecular Biology

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

L Brichta et al.

HUMAN MOLECULAR GENETICS (2003)

Article Clinical Neurology

Downregulation of Bcl-2 proteins in type I spinal muscular atrophy motor neurons during fetal development

C Soler-Botija et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)

Article Clinical Neurology

Oxidative stress and disturbed glutamate transport in spinal muscular atrophy

M Hayashi et al.

BRAIN & DEVELOPMENT (2002)